Contract 36F79724D0142
Biofrontera Inc · Department Of Veterans Affairs · September 26, 2024
Biofrontera Inc was awarded a federal contract by Department Of Veterans Affairs on September 26, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 25, 2026. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79724D0142
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 26, 2024
- Latest action
- February 25, 2026
Description
TPR.
Modification timeline
-
February 25, 2026Mod P00006 · Supplemental Agreement For Work Within Scope$0
-
February 25, 2026Mod P00006$0
-
December 9, 2025Mod P00005 · Supplemental Agreement For Work Within Scope2026 PL.$0
-
August 11, 2025Mod P00004 · Supplemental Agreement For Work Within Scope$0
-
September 26, 2024Mod P00001 · Supplemental Agreement For Work Within ScopeTPR$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79724D0142?
Contract 36F79724D0142 is a federal contract awarded to Biofrontera Inc by Department Of Veterans Affairs on September 26, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79724D0142?
Biofrontera Inc won contract 36F79724D0142 from Department Of Veterans Affairs.
How much is contract 36F79724D0142 worth?
Contract 36F79724D0142 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.